Propanc Biopharma

(NASDAQ) PPCB

Current Price$0.11

Market Cap$2.26M

Since IPO (2012)-100%

5 Year-100%

1 Year-97%

1 Month-8%

Propanc Biopharma Financials at a Glance

Market Cap

$2.26M

Revenue (TTM)

$29.90K

Net Income (TTM)

$66.07M

EPS (TTM)

$-13.54

P/E Ratio

-0.01

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.11

Volume

950

Open

$0.11

Price

$0.11

Volume

950

Open

$0.11

Previous Close

$0.11

Daily Range

$0.10 - $0.11

52-Week Range

$0.10 - $10.81

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.11

Volume

950

Open

$0.11

Previous Close

$0.11

Daily Range

$0.10 - $0.11

52-Week Range

$0.10 - $10.81

PPCB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Propanc Biopharma

Industry

Biotechnology

Sector

Health Care

Employees

CEO

James Andrew Nathanielsz

Website

www.propanc.com

Headquarters

Camberwell, VIC 3124, AU

PPCB Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

-2177%

Net Income Margin

-2209%

Return on Equity

-2100%

Return on Capital

-6%

Return on Assets

-4%

Earnings Yield

-100.00%

Dividend Yield

0.00%

Payout Ratio

-1.41%

Stock Overview

Market Cap

$2.26M

Shares Outstanding

21.86M

Volume

950

Avg. Volume

3.97M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$57.28M

EBITDA

$58.34M

Operating Cash Flow

$405.17K

Capital Expenditure

$0.00

Free Cash Flow

$405.17K

Cash & ST Invst.

$12.09K

Total Debt

$1.73M

Propanc Biopharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$6.03K

-39.2%

Gross Margin

0.00%

N/A

Market Cap

$2.26M

N/A

Market Cap/Employee

$2.26M

N/A

Employees

N/A

Net Income

$3.09M

-618.6%

EBITDA

$3.65M

-1090.8%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$1.12M

+6.0%

Accounts Receivable

$16.99K

+761.3%

Inventory

$0.00

N/A

Long Term Debt

$1.07M

+1200.3%

Short Term Debt

$613.97K

-45.5%

Return on Assets

-4.37%

N/A

Return on Invested Capital

-5.67%

N/A

Free Cash Flow

$999.14K

-15832.7%

Operating Cash Flow

$999.14K

-15832.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SRBCFSirona Biochem Corp.

SRBCFSirona Biochem Corp.$0.01+0.00%

SYGGFSynairgen plc

SYGGFSynairgen plc$0.00+0.00%

ZHCLFZenith Capital Corp.

ZHCLFZenith Capital Corp.$0.06+0.00%

PRVCFPreveCeutical Medical Inc.

PRVCFPreveCeutical Medical Inc.$0.02+0.00%

IMUCEOM Pharmaceuticals Holdings, Inc.

IMUCEOM Pharmaceuticals Holdings, Inc.$0.09+0.00%

HOOKHOOKIPA Pharma Inc.

HOOKHOOKIPA Pharma Inc.$1.19+1.28%

TELIFTelescope Innovations Corp.

TELIFTelescope Innovations Corp.$0.35+1.11%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

AAPLApple

AAPLApple$280.14+0.03%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

Questions About PPCB

What is the current price of Propanc Biopharma?

Propanc Biopharma is trading at $0.11 per share.

What is the 52-week range for Propanc Biopharma?

Over the past 52 weeks, Propanc Biopharma has traded between $0.10 and $10.81.

How much debt does Propanc Biopharma have?

As of the most recent reporting period, Propanc Biopharma reported total debt of $1.65M.

How much cash does Propanc Biopharma have on hand?

Propanc Biopharma reported $561,237 in cash and cash equivalents in its most recent financial results.

What is Propanc Biopharma’s dividend yield?

Propanc Biopharma does not currently have a dividend yield.

Propanc Biopharma

Propanc Biopharma Financials at a Glance

PPCB News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Propanc Biopharma

PPCB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Propanc Biopharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PPCB

What is the current price of Propanc Biopharma?

What is the 52-week range for Propanc Biopharma?

How much debt does Propanc Biopharma have?

How much cash does Propanc Biopharma have on hand?

What is Propanc Biopharma’s dividend yield?

Premium Investing Services